Usefulness of prescription monitoring programs for surveillance—analysis of Schedule II opioid prescription data in Massachusetts, 1996–2006

Electronic prescription monitoring programs (PMPs) have been developed in many states as a public health surveillance tool. We analyze herein 11 years of Massachusetts PMP data to evaluate trends in opioid prescribing, dispensing, and usage.

[1]  Patrick M. O'Malley,et al.  Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2004. , 2003 .

[2]  J. Havens,et al.  Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users. , 2007, Drug and alcohol dependence.

[3]  J. R. Cooper,et al.  Prescription drug diversion control and medical practice. , 1992, JAMA.

[4]  R. Shader,et al.  A Controlled Study of the Effects of State Surveillance on Indicators of Problematic and Non-Problematic Benzodiazepine Use in a Medicaid Population , 2004, International journal of psychiatry in medicine.

[5]  J. L. Dahl,et al.  A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. , 2004, Journal of pain and symptom management.

[6]  S. Fishman,et al.  Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain. , 2004, Pain medicine.

[7]  L. Holland,et al.  An Evaluation of Prescription Drug Monitoring Programs , 2006 .

[8]  L. Simoni-Wastila,et al.  BALANCING DIVERSION CONTROL AND MEDICAL NECESSITY: THE CASE OF PRESCRIPTION DRUGS WITH ABUSE POTENTIAL , 2001, Substance use & misuse.

[9]  A. Gilson,et al.  Drug crime is a source of abused pain medications in the United States. , 2005, Journal of pain and symptom management.

[10]  Grant M. Carrow,et al.  Update on prescription monitoring in clinical practice: a survey study of prescription monitoring program administrators. , 2008, Pain medicine.

[11]  D. Clode,et al.  Seeking drugs or seeking help? Escalating “doctor shopping” by young heroin users before fatal overdose , 2004, The Medical journal of Australia.

[12]  L. Paulozzi,et al.  Opioid analgesics and rates of fatal drug poisoning in the United States. , 2006, American journal of preventive medicine.

[13]  Patrick M. O'Malley,et al.  Monitoring the Future: National Results on Adolescent Drug Use. Overview of Key Findings, 2003. NIH Publication No. 04-5506. , 2004 .

[14]  R. J. Rose,et al.  Behavioral Monitoring and Urine Toxicology Testing in Patients Receiving Long-Term Opioid Therapy , 2003, Anesthesia and analgesia.

[15]  Nathaniel Katz,et al.  Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases. , 1996, Journal of pain and symptom management.

[16]  Grant M. Carrow,et al.  Pain management and prescription monitoring. , 2002, Journal of pain and symptom management.

[17]  J. Inciardi,et al.  Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. , 2007, Pain medicine.

[18]  D. Brushwood.  Maximizing the Value of Electronic Prescription Monitoring Programs , 2003, Journal of Law, Medicine & Ethics.

[19]  S. Soumerai,et al.  A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders. , 2004, Clinical therapeutics.

[20]  J. Benneyan,et al.  Foundations of Opioid Risk Management , 2007, The Clinical journal of pain.

[21]  O. Blin,et al.  Impact of a prescription monitoring program on doctor‐shopping for high dosage buprenorphine , 2009, Pharmacoepidemiology and drug safety.